HEADER PROTEIN TRANSPORT 28-JUN-11 2LF4 TITLE STRUCTURE OF A MONOMERIC MUTANT OF THE HIV-1 CAPSID PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG POLYPROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: GAG; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DE3; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA 2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET20B-HIV1CA KEYWDS FULLERENE, PROTEIN TRANSPORT EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR R.S.SHIN,Y.TZOU,N.KRISHNA REVDAT 2 14-JUN-23 2LF4 1 REMARK SEQADV REVDAT 1 09-NOV-11 2LF4 0 JRNL AUTH R.SHIN,Y.M.TZOU,N.R.KRISHNA JRNL TITL STRUCTURE OF A MONOMERIC MUTANT OF THE HIV-1 CAPSID PROTEIN. JRNL REF BIOCHEMISTRY V. 50 9457 2011 JRNL REFN ISSN 0006-2960 JRNL PMID 21995733 JRNL DOI 10.1021/BI2011493 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TOPSPIN 1.3, CYANA 2.1 REMARK 3 AUTHORS : BRUKER BIOSPIN (TOPSPIN), GUNTERT, MUMENTHALER AND REMARK 3 WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 50,000 STEPS REMARK 4 REMARK 4 2LF4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000102315. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM [U-98% 15N] HIV-1 CA, 25 MM REMARK 210 SODIUM CHLORIDE, 25 MM [U-99% 2H] REMARK 210 SODIUM ACETATE, 10 MM [U-99% 2H] REMARK 210 DTT, 0.02 % SODIUM AZIDE, 0.1 REMARK 210 MM AEBSF PROTEASE INHIBITOR, 1 REMARK 210 MM [U-99% 2H] EDTA, 90% H2O/10% REMARK 210 D2O; 2 MM [U-98% 13C; U-98% 15N] REMARK 210 HIV-1 CA, 25 MM SODIUM CHLORIDE, REMARK 210 25 MM [U-99% 2H] SODIUM ACETATE, REMARK 210 10 MM [U-99% 2H] DTT, 0.02 % REMARK 210 SODIUM AZIDE, 0.1 MM AEBSF REMARK 210 PROTEASE INHIBITOR, 1 MM [U-99% REMARK 210 2H] EDTA, 90% H2O/10% D2O; 2 MM REMARK 210 [U-98% 13C; U-98% 15N] HIV-1 CA, REMARK 210 25 MM SODIUM CHLORIDE, 25 MM [U- REMARK 210 99% 2H] SODIUM ACETATE, 10 MM [U- REMARK 210 99% 2H] DTT, 0.02 % SODIUM AZIDE, REMARK 210 0.1 MM AEBSF PROTEASE INHIBITOR, REMARK 210 1 MM [U-99% 2H] EDTA, 100% D2O; REMARK 210 2 MM [U-98% 13C; U-98% 15N] HIV- REMARK 210 1 CA, 25 MM SODIUM CHLORIDE, 25 REMARK 210 MM [U-99% 2H] SODIUM ACETATE, 10 REMARK 210 MM [U-99% 2H] DTT, 0.02 % SODIUM REMARK 210 AZIDE, 0.1 MM AEBSF PROTEASE REMARK 210 INHIBITOR, 1 MM [U-99% 2H] EDTA, REMARK 210 90% H2O/10% D2O; 2 MM [U-98% 13C; REMARK 210 U-98% 15N] HIV-1 CA, 25 MM REMARK 210 SODIUM CHLORIDE, 25 MM [U-99% 2H] REMARK 210 SODIUM ACETATE, 10 MM [U-99% 2H] REMARK 210 DTT, 0.02 % SODIUM AZIDE, 0.1 REMARK 210 MM AEBSF PROTEASE INHIBITOR, 1 REMARK 210 MM [U-99% 2H] EDTA, 100% D2O; 2 REMARK 210 MM [U-98% 13C; U-98% 15N] HIV-1 REMARK 210 CA, 25 MM SODIUM CHLORIDE, 25 MM REMARK 210 [U-99% 2H] SODIUM ACETATE, 10 MM REMARK 210 [U-99% 2H] DTT, 0.02 % SODIUM REMARK 210 AZIDE, 0.1 MM AEBSF PROTEASE REMARK 210 INHIBITOR, 1 MM [U-99% 2H] EDTA, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-15N SOFAST REMARK 210 HMQC; 2D 1H-13C HSQC; 3D CBCA(CO) REMARK 210 NH; 3D HNCO; 3D HNCA; 3D HNCACB; REMARK 210 3D HCCH-TOCSY; 3D HCCH-COSY; 3D REMARK 210 1H-15N NOESY; 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 1.3, NMRDRAW, NMRPIPE, REMARK 210 XEASY, CYANA 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 500 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 VAL A 232 REMARK 465 GLU A 233 REMARK 465 HIS A 234 REMARK 465 HIS A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 30 -69.11 -128.05 REMARK 500 1 ALA A 31 -76.06 173.23 REMARK 500 1 ALA A 47 -168.61 -62.71 REMARK 500 1 THR A 58 36.64 -93.62 REMARK 500 1 ALA A 88 103.20 -51.51 REMARK 500 1 GLN A 95 -167.34 -100.14 REMARK 500 1 THR A 107 -63.73 -94.09 REMARK 500 1 PRO A 123 89.30 -69.72 REMARK 500 1 PHE A 168 -71.91 -61.56 REMARK 500 1 GLU A 175 -75.11 -118.40 REMARK 500 1 ALA A 177 63.84 -150.39 REMARK 500 1 SER A 178 80.30 -153.10 REMARK 500 1 GLN A 179 -75.92 -147.06 REMARK 500 1 GLU A 180 13.67 -143.77 REMARK 500 1 ALA A 184 -36.85 -158.43 REMARK 500 1 LYS A 227 172.70 -58.78 REMARK 500 1 ARG A 229 -174.68 -60.84 REMARK 500 2 ALA A 31 -167.27 49.61 REMARK 500 2 THR A 58 41.07 -96.24 REMARK 500 2 HIS A 62 77.96 -102.59 REMARK 500 2 MET A 96 177.03 -56.07 REMARK 500 2 ARG A 100 -169.79 -112.93 REMARK 500 2 PRO A 123 95.50 -69.86 REMARK 500 2 PHE A 168 -72.90 -62.86 REMARK 500 2 GLU A 175 -164.94 -71.25 REMARK 500 2 SER A 178 61.68 -153.05 REMARK 500 2 GLN A 179 -74.61 -129.93 REMARK 500 2 ALA A 184 -39.53 -158.11 REMARK 500 2 LYS A 227 172.83 -58.03 REMARK 500 2 ARG A 229 -174.64 -59.98 REMARK 500 3 ASN A 5 -179.26 -57.74 REMARK 500 3 LYS A 30 -66.51 -130.42 REMARK 500 3 ALA A 31 -81.87 173.11 REMARK 500 3 PHE A 32 49.97 -161.37 REMARK 500 3 SER A 33 166.39 -48.70 REMARK 500 3 PRO A 34 1.17 -69.68 REMARK 500 3 ALA A 47 88.29 49.71 REMARK 500 3 THR A 58 39.19 -93.52 REMARK 500 3 HIS A 62 78.86 -102.00 REMARK 500 3 PRO A 85 98.18 -69.75 REMARK 500 3 MET A 96 177.02 -56.37 REMARK 500 3 THR A 107 -63.37 -91.10 REMARK 500 3 PRO A 123 96.83 -69.73 REMARK 500 3 PHE A 168 -70.78 -60.33 REMARK 500 3 SER A 178 61.13 -152.99 REMARK 500 3 GLN A 179 -75.43 -147.04 REMARK 500 3 VAL A 181 -54.38 -156.15 REMARK 500 3 ALA A 184 -39.51 -158.33 REMARK 500 3 LYS A 227 172.61 -57.57 REMARK 500 3 ARG A 229 -171.47 51.99 REMARK 500 REMARK 500 THIS ENTRY HAS 326 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JYL RELATED DB: PDB REMARK 900 ENTRY SHOWING THE C-TERMINAL DOMAIN OF THIS PROTEIN REMARK 900 RELATED ID: 17738 RELATED DB: BMRB REMARK 900 RELATED ID: 2LF5 RELATED DB: PDB DBREF 2LF4 A 1 231 UNP Q72497 Q72497_9HIV1 133 363 SEQADV 2LF4 MET A 0 UNP Q72497 INITIATING METHIONINE SEQADV 2LF4 ALA A 184 UNP Q72497 TRP 316 ENGINEERED MUTATION SEQADV 2LF4 ALA A 185 UNP Q72497 MET 317 ENGINEERED MUTATION SEQADV 2LF4 VAL A 232 UNP Q72497 EXPRESSION TAG SEQADV 2LF4 GLU A 233 UNP Q72497 EXPRESSION TAG SEQADV 2LF4 HIS A 234 UNP Q72497 EXPRESSION TAG SEQADV 2LF4 HIS A 235 UNP Q72497 EXPRESSION TAG SEQADV 2LF4 HIS A 236 UNP Q72497 EXPRESSION TAG SEQADV 2LF4 HIS A 237 UNP Q72497 EXPRESSION TAG SEQADV 2LF4 HIS A 238 UNP Q72497 EXPRESSION TAG SEQADV 2LF4 HIS A 239 UNP Q72497 EXPRESSION TAG SEQRES 1 A 240 MET PRO ILE VAL GLN ASN LEU GLN GLY GLN MET VAL HIS SEQRES 2 A 240 GLN ALA ILE SER PRO ARG THR LEU ASN ALA TRP VAL LYS SEQRES 3 A 240 VAL VAL GLU GLU LYS ALA PHE SER PRO GLU VAL ILE PRO SEQRES 4 A 240 MET PHE SER ALA LEU SER GLU GLY ALA THR PRO GLN ASP SEQRES 5 A 240 LEU ASN THR MET LEU ASN THR VAL GLY GLY HIS GLN ALA SEQRES 6 A 240 ALA MET GLN MET LEU LYS GLU THR ILE ASN GLU GLU ALA SEQRES 7 A 240 ALA GLU TRP ASP ARG LEU HIS PRO VAL HIS ALA GLY PRO SEQRES 8 A 240 ILE ALA PRO GLY GLN MET ARG GLU PRO ARG GLY SER ASP SEQRES 9 A 240 ILE ALA GLY THR THR SER THR LEU GLN GLU GLN ILE GLY SEQRES 10 A 240 TRP MET THR HIS ASN PRO PRO ILE PRO VAL GLY GLU ILE SEQRES 11 A 240 TYR LYS ARG TRP ILE ILE LEU GLY LEU ASN LYS ILE VAL SEQRES 12 A 240 ARG MET TYR SER PRO THR SER ILE LEU ASP ILE ARG GLN SEQRES 13 A 240 GLY PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE SEQRES 14 A 240 TYR LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL SEQRES 15 A 240 LYS ASN ALA ALA THR GLU THR LEU LEU VAL GLN ASN ALA SEQRES 16 A 240 ASN PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO SEQRES 17 A 240 GLY ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY SEQRES 18 A 240 VAL GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU VAL GLU SEQRES 19 A 240 HIS HIS HIS HIS HIS HIS HELIX 1 1 SER A 16 LYS A 30 1 15 HELIX 2 2 GLU A 35 SER A 44 1 10 HELIX 3 3 THR A 48 THR A 58 1 11 HELIX 4 4 HIS A 62 HIS A 84 1 23 HELIX 5 5 ARG A 100 ALA A 105 1 6 HELIX 6 6 THR A 110 HIS A 120 1 11 HELIX 7 7 PRO A 125 TYR A 145 1 21 HELIX 8 8 SER A 146 ILE A 153 5 8 HELIX 9 9 PRO A 160 ALA A 174 1 15 HELIX 10 10 ALA A 184 ALA A 194 1 11 HELIX 11 11 ASN A 195 GLY A 206 1 12 HELIX 12 12 THR A 210 VAL A 221 1 12 SHEET 1 A 2 ILE A 2 GLN A 4 0 SHEET 2 A 2 MET A 10 HIS A 12 -1 O VAL A 11 N VAL A 3 CISPEP 1 ASN A 121 PRO A 122 1 -0.01 CISPEP 2 ASN A 121 PRO A 122 2 -0.04 CISPEP 3 ASN A 121 PRO A 122 3 0.00 CISPEP 4 ASN A 121 PRO A 122 4 0.01 CISPEP 5 ASN A 121 PRO A 122 5 -0.07 CISPEP 6 ASN A 121 PRO A 122 6 -0.04 CISPEP 7 ASN A 121 PRO A 122 7 -0.08 CISPEP 8 ASN A 121 PRO A 122 8 -0.08 CISPEP 9 ASN A 121 PRO A 122 9 -0.07 CISPEP 10 ASN A 121 PRO A 122 10 -0.06 CISPEP 11 ASN A 121 PRO A 122 11 -0.07 CISPEP 12 ASN A 121 PRO A 122 12 -0.07 CISPEP 13 ASN A 121 PRO A 122 13 -0.02 CISPEP 14 ASN A 121 PRO A 122 14 -0.03 CISPEP 15 ASN A 121 PRO A 122 15 -0.11 CISPEP 16 ASN A 121 PRO A 122 16 -0.01 CISPEP 17 ASN A 121 PRO A 122 17 -0.12 CISPEP 18 ASN A 121 PRO A 122 18 0.01 CISPEP 19 ASN A 121 PRO A 122 19 0.01 CISPEP 20 ASN A 121 PRO A 122 20 -0.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1